- Home
- CLYM vs NAUT Comparison
CLYM vs NAUT Comparison
Compare CLYM & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLYM
- NAUT
- Stock Information
- Founded
- CLYM 2018
- NAUT 2016
- Country
- CLYM United States
- NAUT United States
- Employees
- CLYM N/A
- NAUT N/A
- Industry
- CLYM
- NAUT Biotechnology: Laboratory Analytical Instruments
- Sector
- CLYM
- NAUT Industrials
- Exchange
- CLYM NYSE
- NAUT Nasdaq
- Market Cap
- CLYM 83.8M
- NAUT 95.6M
- IPO Year
- CLYM 2021
- NAUT N/A
- Fundamental
- Price
- CLYM $1.49
- NAUT $0.77
- Analyst Decision
- CLYM Buy
- NAUT Strong Sell
- Analyst Count
- CLYM 1
- NAUT 1
- Target Price
- CLYM $10.00
- NAUT $1.75
- AVG Volume (30 Days)
- CLYM 210.7K
- NAUT 158.7K
- Earning Date
- CLYM 08-13-2025
- NAUT 07-31-2025
- Dividend Yield
- CLYM N/A
- NAUT N/A
- EPS Growth
- CLYM N/A
- NAUT N/A
- EPS
- CLYM N/A
- NAUT N/A
- Revenue
- CLYM N/A
- NAUT N/A
- Revenue This Year
- CLYM N/A
- NAUT N/A
- Revenue Next Year
- CLYM N/A
- NAUT N/A
- P/E Ratio
- CLYM N/A
- NAUT N/A
- Revenue Growth
- CLYM N/A
- NAUT N/A
- 52 Week Low
- CLYM $1.05
- NAUT $0.66
- 52 Week High
- CLYM $8.87
- NAUT $3.09
- Technical
- Relative Strength Index (RSI)
- CLYM N/A
- NAUT 53.25
- Support Level
- CLYM N/A
- NAUT $0.73
- Resistance Level
- CLYM N/A
- NAUT $0.80
- Average True Range (ATR)
- CLYM 0.00
- NAUT 0.05
- MACD
- CLYM 0.00
- NAUT 0.00
- Stochastic Oscillator
- CLYM 0.00
- NAUT 59.36
About CLYM CLIMB BIO INC
Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. its product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has the potential to treat a broad range of B-cell-mediated diseases.
About NAUT Nautilus Biotechnolgy Inc.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis.